AN2 Therapeutics, Inc. Quarterly Assets in USD from Q4 2021 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: AN2 Therapeutics, Inc. quarterly Assets history and growth rate from Q4 2021 to Q3 2024.
AN2 Therapeutics, Inc. Assets for the quarter ending September 30, 2024 was $97.7M, a 36.5% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$97.7M	-$56.1M	-36.5%	Sep 30, 2024	10-Q	2024-11-13
Q2 2024	$108M	+$9.56M	+9.66%	Jun 30, 2024	10-Q	2024-08-13
Q1 2024	$121M	+$30.2M	+33.1%	Mar 31, 2024	10-Q	2024-05-14
Q4 2023	$139M	+$36.2M	+35.3%	Dec 31, 2023	10-Q	2024-11-13
Q3 2023	$154M	+$43.8M	+39.8%	Sep 30, 2023	10-Q	2023-11-09
Q2 2023	$98.9M	-$21.1M	-17.6%	Jun 30, 2023	10-Q	2023-08-10
Q1 2023	$91.1M	-$29.4M	-24.4%	Mar 31, 2023	10-Q	2023-05-11
Q4 2022	$103M	+$37.2M	+57%	Dec 31, 2022	10-K	2024-03-29
Q3 2022	$110M			Sep 30, 2022	10-Q	2022-11-09
Q2 2022	$120M			Jun 30, 2022	10-Q	2022-08-11
Q1 2022	$121M			Mar 31, 2022	10-Q	2022-05-10
Q4 2021	$65.3M			Dec 31, 2021	10-K	2023-03-29

* An asterisk sign (*) next to the value indicates that the value is likely invalid.